COMMUNIQUÉS West-GlobeNewswire

Fibrocell Reports on Interim Results and Progress of Phase 1/2 Clinical Trial of FCX-007 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa

21/05/2018 - 13:00

– FCX-007 well-tolerated up to 52 weeks post-administration – – Continued positive trends noted in wound healing and pharmacology signals, including type VII collagen expression and evidence of anchoring fibrils – – [...]

Microbot Medical Successfully Completes Pre-Clinical Study for its Self-Cleaning Shunt

21/05/2018 - 13:00

Data from Pre-Clinical Study Indicates the Self-Cleaning Shunt has the Potential to be a Viable Technology for Preventing Occlusion in Shunts Used to Treat Hydrocephalus HINGHAM, Mass., May 21, 2018 (GLOBE NEWSWIRE) -- [...]

Avenue Therapeutics Announces Positive Topline Phase 3 Data for Intravenous Tramadol in the Management of Postoperative Pain

21/05/2018 - 12:30

IV tramadol achieved primary and key secondary endpoints, as well as a clear dose response Initiation of second pivotal Phase 3 trial planned for third quarter of 2018 Management to host conference call today at 8:30 a. [...]

BriaCell’s Lead Product Candidate’s Novel Mechanism of Action Published in a Reputable Immunology Journal

21/05/2018 - 12:30

BERKELEY, Calif. and VANCOUVER, British Columbia, May 21, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell") (TSX-V: BCT ) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a [...]

Tetraphase Pharmaceuticals to Present Eravacycline and TP-6076 Data at ASM Microbe 2018

21/05/2018 - 12:00

– Four Abstracts Selected for Poster Presentations – – Presentations Include New Eravacycline Pooled Analysis of IGNITE 1 and IGNITE4 and Data Highlighting the Pre-Clinical Activity of TP-6076 – WATERTOWN, Mass., May 21 [...]

Terveystalo Plc: Managers' Transactions

21/05/2018 - 11:36

TERVEYSTALO PLC MANAGERS' TRANSACTIONS 21 May 2018 at 12:35 EEST ____________________________________________ Person subject to the notification requirement Name: Keskinäinen työeläkevakuutusyhtiö Varma Position: [...]

NovoEight® maintains potency when stored at 40ºC offering people with haemophilia A increased flexibility in their daily lives

21/05/2018 - 10:01

Glasgow, UK, 21 May 2018 - A new long term stability study has shown that haemophilia A treatment NovoEight ® (turoctocog alfa) remains potent after three months exposure to temperatures of 40ºC. 1 The results were [...]

Oasmia Pharmaceutical Completes Spin-off of Veterinary Oncology Assets to Wholly Owned US Subsidiary, AdvaVet, Inc.

21/05/2018 - 08:30

Oasmia Pharmaceutical AB (NASDAQ: OASM), a developer of a new generation of drugs within human and veterinary oncology, today announced the completed transfer of assets into its wholly owned, US-based subsidiary, [...]

Terveystalo Plc: Disclosure under Chapter 9, Section 5 of the Securities Markets Act (Rettig)

21/05/2018 - 08:21

TERVEYSTALO PLC STOCK EXCHANGE RELEASE 21 May 2018 at 9.20 a.m. EEST Terveystalo Plc ("Terveystalo" or the "Company") has received a notification in accordance with Chapter 9, Section 5 of the Finnish Securities Markets [...]

Terveystalo Plc: Disclosure under Chapter 9, Section 5 of the Securities Markets Act (EQT)

21/05/2018 - 08:11

TERVEYSTALO PLC STOCK EXCHANGE RELEASE 21 May 2018 at 9.10 a.m. EEST Terveystalo Plc ("Terveystalo" or the "Company") has received a notification in accordance with Chapter 9, Section 5 of the Finnish Securities Markets [...]

Immunicum AB (publ) Announces End of Enrollment in Phase I/II GIST Clinical Trial

21/05/2018 - 08:01

Press Release 21 May 2018 Immunicum AB (publ) Announces End of Enrollment in Phase I/II GIST Clinical Trial Immunicum AB (publ; IMMU.ST) today announced that the sixth and last patient has been enrolled in the first [...]

Shire plc : Rule 2.9 Announcement

21/05/2018 - 08:01

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 21 May 2018 Shire [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

21/05/2018 - 07:01

REGULATED INFORMATION GHENT, Belgium, 21 May 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

GLPG1690 results in IPF published in The Lancet Respiratory Medicine and presented at ATS

20/05/2018 - 20:31

Mechelen, Belgium; 20 May 2018; 20.30 CET; Galapagos NV (Euronext & NASDAQ: GLPG) announces publication milestones on GLPG1690 in idiopathic pulmonary fibrosis (IPF). In addition to presenting three abstracts on [...]

Solid Biosciences Announces New Preclinical Data at the American Society of Gene and Cell Therapy Annual Meeting

19/05/2018 - 00:45

- Data Reinforce Potential of SGT-001 as an Important Treatment Candidate for DMD - - Company Continues to Advance Gene Therapy Portfolio - CAMBRIDGE, Mass., May 18, 2018 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. ( [...]

Voyager Therapeutics Announces Additional Data at the American Society of Gene and Cell Therapy 2018 Annual Meeting

19/05/2018 - 00:30

Voyager’s gene therapy vector for Friedreich’s ataxia prevents central and peripheral disease progression in preclinical model out to one year after a single administration Durable safety data generated with Voyager’s [...]

BK Ultrasound, Powered by Analogic, Launches bkSpecto Ultrasound System for Urology at the 2018 American Urological Association Annual Meeting

18/05/2018 - 23:19

PEABODY, Mass., May 18, 2018 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq: ALOG ), enabling the world’s medical imaging and aviation security technology, today announced that it will launch the bkSpecto™ ultrasound [...]

Editas Medicine Reports Data Demonstrating Subretinal Injection of EDIT-101 Well-tolerated in Non-human Primates

18/05/2018 - 23:00

Presentation at the Annual Meeting of the American Society of Gene & Cell Therapy CAMBRIDGE, Mass., May 18, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT ), a leading genome editing company, today [...]

National Brain Tumor Society Brings Realities of Glioblastoma to Congress

18/05/2018 - 22:57

National Brain Tumor Society and Senator Lindsey Graham Host Briefing on Glioblastoma to Educate Congressional Offices on Tumor Type Affecting Their Colleague, Senator John McCain Washington, D.C., May 18, 2018 (GLOBE [...]